EW vs TENX · P/E 47, rev $3.39B vs P/E 3.4, $24.1M cap
Edwards Lifesciences Corp (EW) versus Tenax Therapeutics Inc (TENX) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Tenax Therapeutics Inc (TENX) is a biotechnology company listed on US.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported TENX revenue for 2026-06-30 was $0. Net income was -$33.5M. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
EW currently screens at market cap $49.91B and trailing P/E 46.9. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
Not investment advice. Open the EW and TENX stock pages for the full models.
Not investment advice.